(Boursier.com) — Genfit , a late-stage biopharmaceutical company committed to improving the lives of patients with severe chronic liver disease, announces its projected financial schedule for 2022.
February 28: Publication of revenue and cash position as of December 31, 2021
April 7: Publication of 2021 annual results
May 11: Publication of revenue and cash position as of March 31, 2022
May 25: Annual General Meeting
September 28: Publication of 2022 half-year results
November 10: Publication of revenue and cash position as of September 30, 2022.
©2022 Boursier.com